Is Zim Laboratories a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Zim Laboratories Ltd is a average quality company .

Is Zim Laboratories undervalued or overvalued?

The key valuation ratios of Zim Laboratories Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone .

What is Zim Laboratories share price return in the past 10 years?

Data is not available for this company

Is Zim Laboratories a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Zim Laboratories Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

Zim Laboratories Ltd - Stock Valuation and Financial Performance

Name: Zim Laboratories
Brand: Zim Laboratories

BSE: 541400 | NSE: ZIMLAB | Pharmaceuticals & Drugs | Small Cap

Place order

Zim Laboratories Share Price

₹109.75 -1.35 -1.22%
as on 20-Dec'24 16:59

10 Year X-Ray of Zim Laboratories:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis ^P

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	-8.4%	10%	14.2%	16.1%	15%	4.8%	8.1%	12%	17.5%	10.1%	-
Value Creation Index ⓘ	-1.6	-0.3	0.0	0.2	0.1	-0.7	-0.4	-0.1	0.3	-0.3	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	266	268	235	272	332	274	304	329	397	365	385
Sales YoY Gr.	-	0.7%	-12.4%	15.7%	22%	-17.3%	10.7%	8.5%	20.4%	-7.8%	-
Adj EPS ⓘ	0.2	1.7	3.7	2.7	3.2	0.1	1.7	2.1	4.3	2.9	3
YoY Gr.	-	663.6%	118.5%	-27.5%	19.2%	-98.1%	2700%	25%	106.2%	-33%	-
BVPS (₹) ⓘ	19.6	20.5	24.5	28	31	31.2	32.2	34.9	39.9	47.6	48.1
Adj Net Profit ⓘ	1.1	8.1	17.7	12.9	15.3	0.3	8.2	10.2	21.1	14.1	15
Cash Flow from Ops. ⓘ	5.5	22.1	32.1	36.7	37.1	21.3	31.9	47	35.2	11.5	-
Debt/CF from Ops. ⓘ	17	4.4	2.5	2.2	2.1	4.2	2.5	1.1	1.7	9.3	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	3.6%	2%	6.4%	-7.8%
Adj EPS ⓘ	33.2%	-1.8%	20%	-33%
BVPSⓘ	10.3%	8.9%	13.9%	19.5%
Share Price	-	38.8%	44%	-6%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	1	8.3	16.3	10.1	10.7	0.2	5.3	6.3	11.6	6.6	6.3
Op. Profit Mgn % ⓘ	8	11.1	13.5	12.5	12.9	7.2	12.1	11.5	12.9	11	11.1
Net Profit Mgn % ⓘ	0.4	3	7.5	4.7	4.6	0.1	2.7	3.1	5.3	3.9	3.8
Debt to Equity ⓘ	1	1	0.7	0.6	0.5	0.6	0.5	0.3	0.3	0.5	0.2
Working Cap Days ⓘ	217	212	233	226	215	258	225	222	188	215	86
Cash Conv. Cycle ⓘ	87	80	104	89	68	79	52	60	58	95	23

Recent Performance Summary

Net Profit is growing at healthy rate in last 3 years 19.96%

Return on Equity has declined versus last 3 years average to 6.30%

Sales growth has been subdued in last 3 years 6.37%

Sales growth is not so good in last 4 quarters at 8.88%

Latest Financials - Zim Laboratories Ltd.

	Standalone	Consolidated
TTM EPS (₹)	3	3.3
TTM Sales (₹ Cr.)	385	388
BVPS (₹.) ⓘ	48.1	49.8
Reserves (₹ Cr.) ⓘ	185	194
P/BV ⓘ	2.28	2.20
PE ⓘ	36.39	33.11

From the Market
52 Week Low / High (₹)	89.90 / 131.30
All Time Low / High (₹)	14.00 / 151.75
Market Cap (₹ Cr.)	535
Equity (₹ Cr.)	48.7
Face Value (₹)	10
Industry PE ⓘ	44.3

Management X-Ray of Zim Laboratories:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Zim Laboratories

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Zim Laboratories

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	266	268	235	272	332	274	304	329	397	365
Operating Expenses ⓘ	245	239	203	238	289	255	267	292	345	325
Manufacturing Costs	33	14	13	14	21	34	30	38	45	53
Material Costs	162	157	120	141	160	143	159	160	199	171
Employee Cost	23	31	33	41	48	35	34	39	46	51
Other Costs ⓘ	27	37	37	43	61	42	43	54	55	50
Operating Profit ⓘ	21	29	32	34	42	20	37	38	51	40
Operating Profit Margin (%)	8.0%	10.9%	13.4%	12.5%	12.8%	7.2%	12.1%	11.5%	12.9%	11.0%
Other Income ⓘ	2	4	6	3	2	5	2	5	6	5
Interest ⓘ	10	14	10	9	11	13	11	8	6	7
Depreciation ⓘ	7	9	9	10	11	13	15	15	16	15
Exceptional Items ⓘ	-33	-5	0	6	0	0	-5	0	0	0
Profit Before Tax ⓘ	-27	5	18	24	23	-1	9	19	36	23
Tax ⓘ	-5	0	-1	6	7	-3	3	6	11	6
Profit After Tax	-22	5	19	18	16	2	6	13	25	17
PAT Margin (%)	-8.1%	1.9%	7.9%	6.7%	4.8%	0.6%	1.8%	3.9%	6.3%	4.6%
Adjusted EPS (₹)	-4.5	1.1	3.9	3.8	3.3	0.4	1.2	2.7	5.1	3.4
Dividend Payout Ratio (%)	0%	16%	2%	2%	5%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	94	98	118	135	150	151	157	170	194	232
Share Capital ⓘ	8	8	8	8	16	16	16	16	49	49
Reserves ⓘ	86	90	110	127	134	135	141	154	145	183
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	89	91	74	70	62	77	66	36	48	91
Long Term Debt	38	35	28	20	22	27	22	19	25	36
Short Term Debt	51	56	47	50	40	50	45	17	23	55
Trade Payables	64	47	45	66	72	66	65	82	59	63
Others Liabilities ⓘ	19	21	13	22	40	23	29	49	40	57
Total Liabilities ⓘ	266	257	250	294	324	318	318	337	341	443
Fixed Assets
Gross Block	108	120	98	113	130	153	160	174	192	260
Accumulated Depreciation	20	28	9	19	29	42	56	71	85	100
Net Fixed Assetsⓘ	87	92	89	94	101	111	103	103	107	160
CWIP ⓘ	6	3	4	8	13	10	10	11	26	40
Investmentsⓘ	0	0	0	0	5	8	8	8	8	8
Inventories	46	38	35	52	55	56	54	75	54	81
Trade Receivables	81	89	88	88	90	63	64	81	88	100
Cash Equivalents	8	6	6	4	3	3	8	2	2	1
Others Assetsⓘ	38	30	28	48	57	66	70	56	55	51
Total Assets ⓘ	266	257	250	294	324	318	318	337	341	443

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	5	22	32	37	37	21	32	47	35	11
PBT ⓘ	-27	5	18	24	23	-1	14	19	36	23
Adjustment ⓘ	51	29	21	13	24	25	25	21	21	21
Changes in Working Capital ⓘ	-17	-11	-4	4	-8	3	-5	7	-15	-30
Tax Paid ⓘ	-2	-1	-2	-4	-1	-5	-1	0	-7	-3
Cash Flow From Investing Activity ⓘ	-9	-12	-7	-26	-23	-19	-6	-14	-35	-72
Capex	-15	-13	-9	-28	-18	-15	-6	-15	-36	-73
Net Investments	0	1	1	2	-1	-1	0	0	0	1
Others ⓘ	6	0	0	0	-4	-3	0	0	0	0
Cash Flow From Financing Activityⓘ	-3	-10	-25	-10	-15	-2	-26	-33	1	60
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	-3	-4	-5	-3	5	4	-4	-3	3	15
Interest Paid ⓘ	-10	-12	-10	-9	-10	-14	-10	-8	-6	-8
Dividend Paid ⓘ	-1	0	-1	-1	-1	-1	0	0	0	0
Others ⓘ	11	5	-10	3	-9	9	-11	-22	3	52
Net Cash Flow ⓘ	-7	0	0	1	-1	0	0	0	1	-1

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	-20.51	5.34	17.27	14.45	11.22	1.16	3.64	7.96	13.73	7.86
ROCE (%)	-8.39	9.97	14.24	16.08	14.96	4.75	8.12	12.02	17.48	10.13
Asset Turnover Ratio	1.04	1.06	0.95	1.01	1.07	0.86	0.96	1.01	1.17	0.93
PAT to CFO Conversion(x)	N/A	4.4	1.68	2.06	2.31	10.5	5.33	3.62	1.4	0.65
Working Capital Days
Receivable Days	119	112	134	118	98	102	77	80	78	94
Inventory Days	51	55	55	58	59	74	67	72	59	67
Payable Days	125	129	140	144	158	176	151	167	130	130

Zim Laboratories Ltd Stock News

Zim Laboratories Ltd FAQs

What is the share price of Zim Laboratories?

Company share prices are keep on changing according to the market conditions. The closing price of Zim Laboratories on 20-Dec-2024 16:59 is ₹109.8.

What is the market cap of Zim Laboratories?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 20-Dec-2024 16:59 the market cap of Zim Laboratories stood at ₹534.8.

What is the P/E ratio of Zim Laboratories?

The latest P/E ratio of Zim Laboratories as of 20-Dec-2024 16:59 is 36.39.

What is the P/B ratio of Zim Laboratories?

The latest P/B ratio of Zim Laboratories as of 20-Dec-2024 16:59 is 2.28.

What is the 52-week high and low of Zim Laboratories?

The 52-week high of Zim Laboratories is ₹131.3 and the 52-week low is ₹89.90.

What is the TTM revenue of Zim Laboratories?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Zim Laboratories is ₹384.9 ( Cr.) .

About Zim Laboratories Ltd

ZIM Laboratories Limited is a public limited company domiciled in India engaged in the manufacturing of formulation on drugs. The company also has wholly owned subsidiaries (Zim Laboratories FZE,UAE , SIA Zim Laboratories Limited, Latvia and Zim Health Technologies Limited, India) (the Company and its subsidiaries are together referred to as 'the Group') which are engaged in manufacturing & wholesale of pharmaceutical products, market research and research & development activities.

Business area of the company

The company is engaged in the manufacturing of formulation on drugs and pre formulation on ingredients in India and marketing and selling these within and outside India.